By releasing IL‐1β, OSCC cells enhance tube formation capacity of LECs via IL‐1β directly binding to IL‐1R‐1 in LECs, suggesting the potentials of IL‐1β/IL‐1R‐1 axis in promoting cancer‐related lymphangiogenesis and LN metastasis of OSCC. Here, IL1B is linked to cancer.